Related Experiment Video
Updated: Aug 18, 2026

Development of a Hepatitis B Virus Reporter System to Monitor the Early Stages of the Replication Cycle
Published on: February 1, 2017
[Surveillance in children of mothers positive to hepatitis B surface antigen, 2000-2002]
Marité Bello Corredor1, Licel de los Angeles Rodriguez Lay, Graciela Delgado González
1Instituto de Medicina Tropical Pedro Kouri, Apartado 601, Marianao 13, Ciudad de La Habana, Cuba. ciipk@ipk.sld.cu
Insights
Hepatitis B vaccination at birth effectively prevents perinatal infection in infants born to HBsAg-positive mothers. This surveillance program highlights high maternal positivity and significant infant seroprotection, demonstrating vaccine efficacy.
Area of Science:
- * Hepatology and Virology
- * Immunization and Public Health
Context:
- * Cuba's long-standing 10-year surveillance program for perinatal Hepatitis B control.
- * High perinatal infection risk for infants born to Hepatitis B surface antigen (HBsAg)-positive mothers.
- * Availability of a safe and effective Hepatitis B vaccine in Cuba.
Purpose:
- * To assess the effectiveness of a Hepatitis B vaccination program in preventing perinatal transmission.
- * To evaluate the seropositivity rates of HBsAg in mothers and infants.
- * To determine the seroprotection levels and vaccine efficacy in infants.
Summary:
- * A study of 121 mother-infant pairs in Cuba found 100% HBsAg positivity in mothers.
- * Infant HBsAg positivity was 5.7%, while seroprotection in negative infants reached 94.7% with a Geometric Mean Titer (GMT) of 233.3 UI/L.
- * The vaccine's Efficacy Index ranged from 95.9% to 99.3%, with normoresponsive children predominating (52.6%).
Impact:
- * Demonstrates the critical role of early detection of HBsAg-positive mothers and timely infant vaccination.
- * Provides evidence for the high efficacy of the Hepatitis B vaccine in preventing infant infections.
- * Supports the continuation and strengthening of national immunization programs for Hepatitis B control.
Abstract:
This study was made as part of the Surveillance Program that has been implemented for 10 years for the perinatal control of hepatitis B in children of positive mothers. The control of hepatitis B is possible thanks to the existance of the vaccines against this entity. In Cuba, there is a safe and effective vaccine for its prevention. The perinatal infection risk among children of mothers positive to hepatitis B surface antigen (HbsAg) is high. Many of these infections may be prevented if mothers positive to HbsAg are early detected and their children are vaccinated at birth. 121 serum samples from positive mothers and their respective 7-month-old children from all over the country that were received at the National Viral Hepatitis Reference Laboratory of "Pedro Kouri" Tropical Medicine Institute were studied from September to December, 2000. All the samples underwent the test to detect HbsAg and anti-HBs antibodies were investigated in children negative to HbsAg. 100% of positivity to HBsAg was found among mothers. 5.7% of positivity to this antigen was obtained in children. In negative children the seroprotection attained in this group was 94.7% with an anti-HBs Geometric Mean Titer (GMT) of 233.3 UI/L. The normoresponsive children predominated with 52.6%. The Efficacy Index of the vaccine used ranged from 95.9% to 99.3%.
Related Concept Videos
Hepatitis
Viral Hepatitis I: Introduction
